The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 1, 2011, Pages 17-24

  Wildeboer Andrud, Kristin M ^a,b   Stevens, Karen E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

bungarotoxin; DBA 2 mice; Dihydro erythroidine; Nicotinic acetylcholine receptors; Sensory inhibition; Varenicline

Indexed keywords

BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; VARENICLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DBA 2 MOUSE; DRUG EFFECT; EVOKED AUDITORY RESPONSE; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RECEPTOR BLOCKING; SMOKING CESSATION; TREATMENT OUTCOME;

ACOUSTIC STIMULATION; ANIMALS; BENZAZEPINES; EVOKED POTENTIALS, AUDITORY; MALE; MICE; MICE, INBRED DBA; NEURAL INHIBITION; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PEPTIDE FRAGMENTS; QUINOXALINES; RECEPTORS, NICOTINIC; SMOKING CESSATION;

MUS; RODENTIA;

EID: 80051527128     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.07.001     Document Type: Article

References (68)

1. L.E. Adler, R. Freedman, R.G. Ross, A. Olincy, and M.C. Waldo Elementary phenotypes in the neurobiological and genetic study of schizophrenia Biol Psychiatry 46 1999 8 18 (Pubitemid 29296814)
2. L.E. Adler, L.D. Hoffer, A. Wiser, and R. Freedman Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am J Psychiatry 150 1993 1856 1861 (Pubitemid 23356580)
3. L.E. Adler, A. Olincy, E.M. Cawthra, K.A. McRae, J.G. Harris, and H.T. Nagamoto Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients Am J Psychiatry 161 2004 1822 1828 (Pubitemid 39314676)
4. F. Alhatem, and J.E. Black Varenicline-induced mania in a bipolar patient Clin Neuropharmacol 32 2009 117 118
5. M. Alkondon, and E.X. Albuquerque Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus J Neurophysiol 86 2001 3043 3055 (Pubitemid 33139070)
6. M. Alkondon, E.F. Pereira, H.M. Eisenberg, and E.X. Albuquerque Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices J Neurosci 19 1999 2693 2705 (Pubitemid 29162417)
7. K. Cahill, L.F. Stead, and T. Lancaster Nicotine receptor partial agonists for smoking cessation. Cochrane database of systematic reviews (Online) 2008 CD006103
8. P.B.R. Clarke, D. Schwartz, S.M. Paul, C.B. Pert, and A. Pert Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin J Neurosci 5 1985 1307 1315 (Pubitemid 15098442)
9. J.W. Coe, P.R. Brooks, M.G. Vetelino, M.C. Wirtz, E.P. Arnold, and J. Huang Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J Med Chem 48 2005 3474 3477 (Pubitemid 40664098)
10. C. Cohen, O.E. Bergis, F. Galli, A.W. Lochead, S. Jegham, and B. Biton SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation J Pharmacol Exp Ther 306 2003 407 420 (Pubitemid 36734399)
11. D. Colquhoun, and D.C. Ogden Activation of ion channels in the frog end-plate by high concentrations of acetylcholine J Physiol 395 1988 131 159 (Pubitemid 18029190)
12. B.A. DiPaula, and M.D. Thomas Worsening psychosis induced by varenicline in a hospitalized psychiatric patient Pharmacotherapy 29 2009 852 857
13. P. Dobelis, M.J. Marks, P. Whiteaker, S.A. Balogh, A.C. Collins, and J.A. Stitzel A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function Mol Pharmacol 62 2002 334 342 (Pubitemid 34804114)
14. A.E. Evins, and D.C. Goff Varenicline treatment for smokers with schizophrenia: a case series J Clin Psychiatry 69 2008 1016 (Pubitemid 351944959)
15. S.H. Fatemi Varenicline efficacy and tolerability in a subject with schizophrenia Schizophr Res 103 2008 328 329
16. C. Fenster, M.L. Beckman, J.C. Parker, E.B. Sheffield, T.L. Whitworth, and M.W. Quick Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C Mol Pharmacol 55 1999 432 443 (Pubitemid 29128099)
17. R. Freedman Exacerbation of schizophrenia by varenicline Am J Psychiatry 164 2007 1269
18. R. Freedman, H. Coon, M. Myles-Worsley, A. Orr-Urtreger, A. Olincy, and A. Davis Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc Natl Acad Sci USA 94 1997 587 592 (Pubitemid 27053677)
19. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol Psychiatry 38 1995 22 33
20. C.L. Gentry, and R.J. Lukas Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure Curr Drug Targets CNS Neurol Disord 1 2002 359 385
21. D. Gonzales, S.I. Rennard, M. Nides, C. Oncken, S. Azoulay, and C.B. Billing Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA 296 2006 47 55
22. R. Gray, A.S. Rajan, K.A. Radcliffe, M. Yakehiro, and J.A. Dani Hippocampal synaptic transmission enhanced by low concentrations of nicotine Nature 383 1996 713 716 (Pubitemid 26360646)
23. T. Grunwald, N.N. Boutros, N. Pezer, J. von Oertzen, G. Fernandez, and C. Schaller Neuronal substrates of sensory gating within the human brain Biol Psychiatry 53 2003 511 519 (Pubitemid 36331890)
24. K. Hashimoto, M. Iyo, R. Freedman, and K.E. Stevens Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors Psychopharmacology 183 2005 13 19 (Pubitemid 41484178)
25. D.A. Henze, N.N. Urban, and G. Barrionuevo The multifarious hippocampal mossy fiber pathway: a review Neuroscience 98 2000 407 427 (Pubitemid 30408162)
26. Institute of Laboratory Animal Resources CoLS, National Research Council. Guide for the care and use of laboratory animals 1996 National Academy Press Washington, D.C
27. D.E. Jorenby, J.T. Hays, N.A. Rigotti, S. Azoulay, E.J. Watsky, and K.E. Williams Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA 296 2006 56 63
28. B. Katz, and S. Thesleff A study of the desensitization produced by acetylcholine at the motor end-plate J Physiol 138 1957 63 80
29. H. Kim, B.A. Flanagin, C. Qin, R.L. Macdonald, and J.A. Stitzel The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs Neuropharmacology 45 2003 345 354 (Pubitemid 36836131)
30. I. Kohen, and N. Kremen Varenicline-induced manic episode in a patient with bipolar disorder Am J Psychiatry 164 2007 1269 1270 (Pubitemid 47292424)
31. S. Leonard, C. Adams, C.R. Breese, L.E. Adler, P. Bickford, and W. Byerley Nicotinic receptor function in schizophrenia Schizophr Bull 22 1996 431 445 (Pubitemid 26295346)
32. M.J. Marks, E. Romm, S.M. Campbell, and A.C. Collins Variation of nicotinic binding sites among inbred strains Pharmacol Biochem Behav 33 1989 679 689 (Pubitemid 19237547)
33. J.B. McClure, G.E. Swan, S.L. Catz, L. Jack, H. Javitz, and T. McAfee Smoking outcome by psychiatric history after behavioral and varenicline treatment J Subst Abuse Treat 38 2010 394 402
34. K.B. Mihalak, F.I. Carroll, and C.W. Luetje Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol Pharmacol 70 2006 801 805 (Pubitemid 44268437)
35. C.L. Miller, and R. Freedman The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli Neuroscience 69 1995 371 381
36. A.E. Morstad, E.C. Kutscher, W.K. Kennedy, and R.M. Carnahan Hypomania with agitation associated with varenicline use in bipolar II disorder Ann Pharmacother 42 2008 288 289 (Pubitemid 351238580)
37. M. Nides, C. Oncken, D. Gonzales, S. Rennard, E.J. Watsky, and R. Anziano Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up Arch Intern Med 166 2006 1561 1568 (Pubitemid 44232363)
38. E.L. Ochoa Varenicline reduced smoking behaviour in a mentally ill person J Psychopharmacol 23 2009 340 341
39. A. Olincy, J.G. Harris, L.L. Johnson, V. Pender, S. Kongs, and D. Allensworth Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia Arch Gen Psychiatry 63 2006 630 638 (Pubitemid 43848294)
40. C. Oncken, D. Gonzales, M. Nides, S. Rennard, E. Watsky, and C.B. Billing Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation Arch Intern Med 166 2006 1571 1577 (Pubitemid 44232364)
41. R.L. Papke, and J.S. Thinschmidt The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes Neurosci Lett 256 1998 163 166 (Pubitemid 28546915)
42. R.L. Papke, L. Wecker, and J.A. Stitzel Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes J Pharmacol Exp Ther 333 2010 501 518
43. J.R. Pauly, J.A. Stitzel, M.J. Marks, and A.C. Collins An autoradiographic analysis of choinergic receptors in mouse brain Brain Res Bull 22 1989 453 459 (Pubitemid 19165329)
44. G. Paxinos, and K.B.J. Franklin The mouse brain in stereotaxic coordinates 2001 Academic Press San Diego
45. M.K. Popkin Exacerbation of recurrent depression as a result of treatment with varenicline Am J Psychiatry 165 2008 774 (Pubitemid 351810551)
46. A.J. Pumariega, R. Nelson, and L. Rotenberg Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression CNS Spectr 13 2008 511 514 (Pubitemid 351960775)
47. R.J. Radek, H.M. Miner, N.A. Bratcher, M.W. Decker, M. Gopalakrishnan, and R.S. Bitner Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating Psychopharmacology 187 2006 47 55 (Pubitemid 43876915)
48. B.M. Raidoo, and E.C. Kutscher Visual hallucinations associated with varenicline: a case report J Med Case Rep 3 2009 7560
49. C. Reperant, S. Pons, E. Dufour, H. Rollema, A.M. Gardier, and U. Maskos Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area Neuropharmacology 58 2010 346 350
50. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, and L.A. Lebel Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994 (Pubitemid 46227486)
51. H. Rollema, J.W. Coe, L.K. Chambers, R.S. Hurst, S.M. Stahl, and K.E. Williams Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation Trends Pharmacol Sci 28 2007 316 325 (Pubitemid 47016686)
52. H. Rollema, M. Hajos, P.A. Seymour, R. Kozak, M.J. Majchrzak, and V. Guanowsky Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochem Pharmacol 78 2009 813 824
53. N.D. Rudnick, C. Koehler, M.R. Picciotto, and S.J. Siegel Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials Psychopharmacology 202 2009 745 751
54. N.D. Rudnick, A.A. Strasser, J.M. Phillips, C. Jepson, F. Patterson, and J.M. Frey Mouse model predicts effects of smoking and varenicline on event-related potentials in humans Nicotine Tob Res 12 2010 589 597
55. J.K. Simosky, K.E. Stevens, L.E. Adler, and R. Freedman Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism Psychopharmacology 165 2003 386 396 (Pubitemid 36223080)
56. J.K. Simosky, K.E. Stevens, W.R. Kem, and R. Freedman Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice Biol Psychiatry 50 2001 493 500 (Pubitemid 32971880)
57. L.I. Spirling, J.A. Stapleton, and G. Sutherland Suicidal ideation and varenicline: a possible case of mistaken adverse drug reaction? J Clin Psychiatry 69 2008 1834 1835
58. K.E. Stevens, R. Freedman, A.C. Collins, M. Hall, S. Leonard, and M.J. Marks Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains Neuropsychopharmacology 15 1996 152 162 (Pubitemid 26255162)
59. K.E. Stevens, W.R. Kem, V.M. Mahnir, and R. Freedman Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice Psychopharmacology 136 1998 320 327 (Pubitemid 28189660)
60. K.E. Stevens, and K.D. Wear Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models Pharmacol Biochem Behav 57 1997 869 874 (Pubitemid 27334438)
61. J.A. Stitzel, P. Dobelis, M. Jimenez, and A.C. Collins Long sleep and short sleep mice differ in nicotine-stimulated 86Rb + efflux and alpha4 nicotinic receptor subunit cDNA sequence Pharmacogenetics 11 2001 331 339 (Pubitemid 32537407)
62. L.W. Swanson, D.M. Simmons, P.J. Whiting, and J. Lindstrom Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system J Neurosci 7 1987 3334 3342
63. S. Tonstad, P. Tonnesen, P. Hajek, K.E. Williams, C.B. Billing, and K.R. Reeves Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial JAMA 296 2006 64 71
64. B.W. van Bon, H.C. Mefford, B. Menten, D.A. Koolen, A.J. Sharp, and W.M. Nillesen Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome J Med Genet 46 2009 511 523
65. R.E. Vann, J.R. James, J.A. Rosecrans, and S.E. Robinson Nicotinic receptor inactivation after acute and repeated in vivo nicotine exposures in rats Brain Res 1086 2006 98 103
66. P.H. Venables Input dysfunction in schizophrenia Prog Exp Pers Res 72 1964 1 47
67. K.M. Wildeboer, and K.E. Stevens Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice Brain Res 1224 2008 29 36
68. K.E. Williams, K.R. Reeves, C.B. Billing Jr., A.M. Pennington, and J. Gong A double-blind study evaluating the long-term safety of varenicline for smoking cessation Curr Med Res Opin 23 2007 793 801 (Pubitemid 46646499)